Topics

Voluntis gets FDA marketing approval for Oleena digital therapeutic

03:52 EDT 1 Aug 2019 | Compelo Medical Devices

Digital therapeutics provider Voluntis has secured market authorisation from the US Food and Drug Administration (FDA) for its Oleena software for oncology-related symptoms management and remote patient monitoring.

The post Voluntis gets FDA marketing approval for Oleena digital therapeutic appeared first on NS Medical Devices.

Original Article: Voluntis gets FDA marketing approval for Oleena digital therapeutic

NEXT ARTICLE

More From BioPortfolio on "Voluntis gets FDA marketing approval for Oleena digital therapeutic"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...